Cargando…
Demyelinating Disease following Anti-TNFa Treatment: A Causal or Coincidental Association? Report of Four Cases and Review of the Literature
Tumor necrosis factor antagonists (anti-TNFa) are an established therapeutic option for several autoimmune and inflammatory bowel diseases. Despite their clinical effectiveness, neurological adverse events have been reported and literature data suggest a potential role of anti-TNFa in the induction...
Autores principales: | Andreadou, E., Kemanetzoglou, E., Brokalaki, Ch., Evangelopoulos, M. E., Kilidireas, C., Rombos, A., Stamboulis, E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670521/ https://www.ncbi.nlm.nih.gov/pubmed/23762678 http://dx.doi.org/10.1155/2013/671935 |
Ejemplares similares
-
CNS Demyelination with TNF-α Blockers
por: Kemanetzoglou, Elissavet, et al.
Publicado: (2017) -
Central Nervous System Demyelination in a Charcot-Marie-Tooth Type 1A Patient
por: Koros, Christos, et al.
Publicado: (2013) -
Intermittent Atrioventricular Block following Fingolimod Initiation
por: Gialafos, E., et al.
Publicado: (2014) -
Immune Thrombocytopenia in Tuberculosis: Causal or Coincidental?
por: Srividya, Gopalakrishnan, et al.
Publicado: (2014) -
Changes in the immune system in depression and dementia: causal or coincidental effects?
por: Leonard, Brian E., et al.
Publicado: (2006)